Safety of patients reason for FDA black box warning on droperidol
- PMID: 14742409
- DOI: 10.1213/01.ANE.0000077705.55641.6B
Safety of patients reason for FDA black box warning on droperidol
Comment on
-
Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases.Anesth Analg. 2003 May;96(5):1377-1379. doi: 10.1213/01.ANE.0000063923.87560.37. Anesth Analg. 2003. PMID: 12707137 No abstract available.
References
-
- Habib AS, Gan TJ. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003; 96: 1377–9.
-
- Drolet B, Zhang S, Deschenes D, et al. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectifier potassium current. J Cardiovasc Electrophysiol 1999; 10: 1597–604.
-
- Park WK, Pancrazio JJ, Suh CK, Lynch C 3rd. Myocardial depressant effects of sevoflurane: mechanical and electrophysiologic actions in vitro. Anesthesiology 1996; 84: 1166–76.
-
- Kuenszberg E, Loeckinger A, Kleinsasser A, et al. Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol 2000; 17: 662–4.
-
- Pancrazio JJ, Frazer MJ, Lynch C 3rd. Barbiturate anesthetics depress the resting K+ conductance of myocardium. J Pharmacol Exp Ther 1993; 265: 358–65.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources